Literature DB >> 23917155

Atmospheric transport modelling of time resolved 133Xe emissions from the isotope production facility ANSTO, Australia.

M Schöppner1, W Plastino, N Hermanspahn, E Hoffmann, M Kalinowski, B Orr, R Tinker.   

Abstract

The verification of the Comprehensive Nuclear-Test Ban Treaty (CTBT) relies amongst other things on the continuous and worldwide monitoring of radioxenon. The characterization of the existing and legitimate background, which is produced mainly by nuclear power plants and isotope production facilities, is of high interest to improve the capabilities of the monitoring network. However, the emissions from legitimate sources can usually only be estimated. For this paper historic source terms of (133)Xe emissions from the isotope production facility at ANSTO, Sydney, Australia, have been made available in a daily resolution. Based on these high resolution data, different source term sets with weekly, monthly and yearly time resolution have been compiled. These different sets are then applied together with atmospheric transport modelling (ATM) to predict the concentration time series at two radioxenon monitoring stations. The results are compared with each other in order to examine the improvement of the prediction capability depending on the used time resolution of the most dominant source term in the region.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atmospheric transport modelling; CTBT verification; Environmental radioxenon; Medical isotope production facilities

Mesh:

Substances:

Year:  2013        PMID: 23917155     DOI: 10.1016/j.jenvrad.2013.07.003

Source DB:  PubMed          Journal:  J Environ Radioact        ISSN: 0265-931X            Impact factor:   2.674


  1 in total

1.  Assessment of the announced North Korean nuclear test using long-range atmospheric transport and dispersion modelling.

Authors:  Pieter De Meutter; Johan Camps; Andy Delcloo; Piet Termonia
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.